This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Dec;41(12):603-5.

doi: 10.5414/cpp41603.

DCE-MRI in clinical trials: data acquisition techniques and analysis methods

R Strecker¹, K Scheffler, M Büchert, K Mross, J Drevs, J Hennig

Affiliations

PMID: 14692712
DOI: 10.5414/cpp41603

Review

DCE-MRI in clinical trials: data acquisition techniques and analysis methods

R Strecker et al. Int J Clin Pharmacol Ther. 2003 Dec.

. 2003 Dec;41(12):603-5.

doi: 10.5414/cpp41603.

Authors

R Strecker¹, K Scheffler, M Büchert, K Mross, J Drevs, J Hennig

Affiliation

¹ University Hospital, Albert Ludwigs University, Freiburg, Germany. ralph.strecker@uniklinik-freiburg.de

PMID: 14692712
DOI: 10.5414/cpp41603

No abstract available

PubMed Disclaimer

Similar articles

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
Hylton N. Hylton N. J Clin Oncol. 2006 Jul 10;24(20):3293-8. doi: 10.1200/JCO.2006.06.8080. J Clin Oncol. 2006. PMID: 16829653 Review.
Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT, Shih TT, Chen RC, Tu SY, Hsieh WY, Yang PC. Chen WT, et al. Mol Imaging. 2012 Jul-Aug;11(4):286-300. Mol Imaging. 2012. PMID: 22954145
Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR, Chai WM, Tang L, Wang Y, Fei XC, Han BS, Chen M. Jia WR, et al. Eur J Radiol. 2014 Jul;83(7):1098-1105. doi: 10.1016/j.ejrad.2014.03.027. Epub 2014 Apr 12. Eur J Radiol. 2014. PMID: 24794865
Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
Yan Y, Sun X, Shen B. Yan Y, et al. Oncotarget. 2017 Jun 27;8(26):43491-43505. doi: 10.18632/oncotarget.16482. Oncotarget. 2017. PMID: 28415647 Free PMC article. Review.
Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
Haeck J, Bol K, Bison S, van Tiel S, Koelewijn S, de Jong M, Veenland J, Bernsen M. Haeck J, et al. Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):413-20. doi: 10.1002/cmmi.1643. Epub 2015 May 21. Contrast Media Mol Imaging. 2015. PMID: 25995102

See all similar articles

Cited by

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis.
Mross K, Büchert M, Frost A, Medinger M, Stopfer P, Studeny M, Kaiser R. Mross K, et al. BMC Cancer. 2014 Jul 11;14:510. doi: 10.1186/1471-2407-14-510. BMC Cancer. 2014. PMID: 25012508 Free PMC article. Clinical Trial.
Spatially regularized T(1) estimation from variable flip angles MRI.
Wang H, Cao Y. Wang H, et al. Med Phys. 2012 Jul;39(7):4139-48. doi: 10.1118/1.4722747. Med Phys. 2012. PMID: 22830747 Free PMC article.
Molecular imaging as a tool for translating breast cancer science.
Mankoff DA. Mankoff DA. Breast Cancer Res. 2008;10 Suppl 1(Suppl 1):S3. doi: 10.1186/bcr2126. Epub 2008 Dec 9. Breast Cancer Res. 2008. PMID: 19091007 Free PMC article. Review.
A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.
Cárdenas-Rodríguez J, Howison CM, Matsunaga TO, Pagel MD. Cárdenas-Rodríguez J, et al. Magn Reson Imaging. 2013 Jul;31(6):900-10. doi: 10.1016/j.mri.2012.12.002. Epub 2013 Apr 11. Magn Reson Imaging. 2013. PMID: 23583323 Free PMC article.
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.
Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P; Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK. Leach MO, et al. Br J Cancer. 2005 May 9;92(9):1599-610. doi: 10.1038/sj.bjc.6602550. Br J Cancer. 2005. PMID: 15870830 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information